Reagents, methods and kits for an amphetamine-class fluorescence
polarization immunoassy
    36.
    发明授权
    Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassy 失效
    苯丙胺类荧光偏振免疫用的试剂,方法和试剂盒

    公开(公告)号:US5354693A

    公开(公告)日:1994-10-11

    申请号:US83928

    申请日:1993-06-29

    摘要: A fluorescence polarization immunoassay (FPIA) for detecting the presence of one or more amphetamine-class analytes in a test sample is provided. The immunoassay uses competition between the analyte and a fluorescently labeled tracer for the binding site on an antibody specific for phenethylamine derivatives. The concentration of amphetamine-class analyte in the sample determines the amount of tracer that binds to the antibody. The amount of tracer-antibody complex formed can be quantitatively measured and is inversely proportional to the quantity of analyte in the test sample. The invention relates to tracers, to immunogens used to elicit antibodies for use as assay reagents, and to assay kits incorporating these tracers and assay reagents.

    摘要翻译: 提供了用于检测测试样品中一种或多种苯丙胺类分析物的存在的荧光偏振免疫测定(FPIA)。 免疫测定使用分子和荧光标记的示踪剂之间的竞争,用于苯乙胺衍生物特异性抗体上的结合位点。 样品中苯丙胺类分析物的浓度决定了与抗体结合的示踪剂的量。 可以定量测量形成的示踪剂 - 抗体复合物的量,并且与测试样品中分析物的量成反比。 本发明涉及示踪剂,用于引发用作测定试剂的抗体的免疫原,以及包含这些示踪剂和测定试剂的试剂盒。

    Reagents, methods and kits for an amphetamine-class fluorescence
polarization immunoassay
    37.
    发明授权
    Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay 失效
    用于苯丙胺类荧光偏振免疫测定的试剂,方法和试剂盒

    公开(公告)号:US5248791A

    公开(公告)日:1993-09-28

    申请号:US820729

    申请日:1992-01-14

    摘要: A fluorescence polarization immunoassay (FPIA) for detecting the presence of one or more amphetamine-class analytes in a test sample is provided. The immunoassay uses competition between the analyte and a fluorescently labeled tracer for the binding site on an antibody specific for phenethylamine derivatives. The concentration of amphetamine-class analyte in the sample determines the amount of tracer that binds to the antibody. The amount of tracer/antibody complex formed can be quantitatively measured and is inversely proportional to the quantity of analyte in the test sample. The invention relates to tracers, to immunogens used to elicit antibodies for use as assay reagents, and to assay kits incorporating these tracers and assay reagents.

    摘要翻译: 提供了用于检测测试样品中一种或多种苯丙胺类分析物的存在的荧光偏振免疫测定(FPIA)。 免疫测定使用分子和荧光标记的示踪剂之间的竞争,用于苯乙胺衍生物特异性抗体上的结合位点。 样品中苯丙胺类分析物的浓度决定了与抗体结合的示踪剂的量。 可以定量测量形成的示踪剂/抗体复合物的量,并且与测试样品中分析物的量成反比。 本发明涉及示踪剂,用于引发用作测定试剂的抗体的免疫原,以及包含这些示踪剂和测定试剂的试剂盒。